102 related articles for article (PubMed ID: 24695417)
1. Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system.
Wang A; Guo M; Wang N; Zhao J; Qi W; Muhammad F; Chen L; Guo Y; Nguyen NT; Zhu G
Nanoscale; 2014 May; 6(10):5270-8. PubMed ID: 24695417
[TBL] [Abstract][Full Text] [Related]
2. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
Samiei Foroushani M; Niroumand N; Karimi Shervedani R; Yaghoobi F; Kefayat A; Torabi M
Bioelectrochemistry; 2019 Dec; 130():107347. PubMed ID: 31437809
[TBL] [Abstract][Full Text] [Related]
3. Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
Ren S; Yang J; Ma L; Li X; Wu W; Liu C; He J; Miao L
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31947-31958. PubMed ID: 30179443
[TBL] [Abstract][Full Text] [Related]
4. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
5. Intracellular antioxidants dissolve man-made antioxidant nanoparticles: using redox vulnerability of nanoceria to develop a responsive drug delivery system.
Muhammad F; Wang A; Qi W; Zhang S; Zhu G
ACS Appl Mater Interfaces; 2014; 6(21):19424-33. PubMed ID: 25312332
[TBL] [Abstract][Full Text] [Related]
6. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
7. Versatile Octapod-Shaped Hollow Porous Manganese(II) Oxide Nanoplatform for Real-Time Visualization of Cargo Delivery.
Wei R; Gong X; Lin H; Zhang K; Li A; Liu K; Shan H; Chen X; Gao J
Nano Lett; 2019 Aug; 19(8):5394-5402. PubMed ID: 31286778
[TBL] [Abstract][Full Text] [Related]
8. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
Zhang S; Qian X; Zhang L; Peng W; Chen Y
Nanoscale; 2015 May; 7(17):7632-43. PubMed ID: 25785502
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis and functionalization of manganese oxide nanoparticles for targeted T1-weighted tumor MR imaging.
Luo Y; Yang J; Li J; Yu Z; Zhang G; Shi X; Shen M
Colloids Surf B Biointerfaces; 2015 Dec; 136():506-13. PubMed ID: 26454057
[TBL] [Abstract][Full Text] [Related]
10. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
11. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
14. pH dictates the release of hydrophobic drug cocktail from mesoporous nanoarchitecture.
Muhammad F; Wang A; Guo M; Zhao J; Qi W; Yingjie G; Gu J; Zhu G
ACS Appl Mater Interfaces; 2013 Nov; 5(22):11828-35. PubMed ID: 24138477
[TBL] [Abstract][Full Text] [Related]
15. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
16. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.
Martinez de la Torre C; Grossman JH; Bobko AA; Bennewitz MF
PLoS One; 2020; 15(9):e0239034. PubMed ID: 32946514
[TBL] [Abstract][Full Text] [Related]
17. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
[No Abstract] [Full Text] [Related]
18. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
Huang CC; Khu NH; Yeh CS
Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
